QUENTIS THERAPEUTICS, INC.
Profile
Company Names
QUENTIS THERAPEUTICS, INC.
QUENTIS, INC.
Addresses
430 E 29TH STREET, SUITE 1005, NEW YORK, NY 10016
54 WEST 21ST STREET, SUITE 408, NEW YORK, NY 10010
Phone Numbers
(646) 440-9248
617-330-7000
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$22,674,997.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-02-15
$19,674,997.00
$47,874,995.00
$28,199,998.00
Equity
1
2016-05-27
$3,000,000.00
$3,000,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL
FOLEY
DIRECTOR
CARLO
RIZZUTO
EXECUTIVE OFFICER, DIRECTOR
VENATORX PHARMACEUTICALS, INC.
| QUENTIS THERAPEUTICS, INC.
| PANDION THERAPEUTICS, INC.
| PANDION THERAPEUTICS HOLDCO LLC
| GRAPHITE BIO, INC.
| CENTURY THERAPEUTICS, INC.
| 858 THERAPEUTICS, INC.
| JNANA THERAPEUTICS INC.
| NEXO THERAPEUTICS, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| PEP2TANGO THERAPEUTICS, INC.
AMY
SCHULMAN
DIRECTOR
ARSANIS, INC.
| SUONO BIO, INC.
| QUENTIS THERAPEUTICS, INC.
| GLYMPSE BIO, INC.
| CYCLERION THERAPEUTICS, INC.
| CARDURION PHARMACEUTICALS, INC.
| FRACTYL LABORATORIES INC.
| AMAGMA, INC.
| BYHEART, INC.
| QURALIS CORP
| FRACTYL HEALTH, INC.
| LYNDRA THERAPEUTICS, INC.
| THIRTY MADISON, INC.
| VOLASTRA THERAPEUTICS, INC.
| POLARIS PARTNERS X, L.P.
| SEQUELAE, INC.
| NOETIK INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
